Kimyrsa
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $171,197 | 1,307 | 658 |
| 2023 | $320,139 | 3,030 | 1,502 |
| 2022 | $500,566 | 4,552 | 2,196 |
| 2021 | $86,456 | 1,746 | 1,034 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $409,910 | 210 | 38.0% |
| Food and Beverage | $279,392 | 10,076 | 25.9% |
| Consulting Fee | $240,627 | 46 | 22.3% |
| Travel and Lodging | $74,428 | 272 | 6.9% |
| Unspecified | $40,639 | 2 | 3.8% |
| Education | $33,362 | 29 | 3.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Anchoring Intermittent long acting antimicrobials to medication for opiod use disorder treatment to facilitate structure transitions of care for people who use drugs admitted to the hospital with invasive infections (AIM-STOP) | Melinta Therapeutics, LLC | $39,139 | 0 |
| Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients | Melinta Therapeutics, LLC | $1,500 | 0 |
Top Doctors Receiving Payments for Kimyrsa — Page 14
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Overland Park, KS | $156.33 | 7 |
| , M.D | Infectious Disease | Las Vegas, NV | $156.01 | 3 |
| , M.D | Infectious Disease | Canton, OH | $155.62 | 5 |
| , PA-C | Physician Assistant | Wichita Falls, TX | $155.56 | 2 |
| Kelsey Enlow | Medical | Wichita Falls, TX | $155.56 | 2 |
| , APRN, FNP-C | Nurse Practitioner | Wichita Falls, TX | $155.56 | 2 |
| , M.D | Emergency Medicine | Wichita Falls, TX | $155.56 | 2 |
| Rachel Reitan | Acute Care | Wichita Falls, TX | $155.56 | 2 |
| , M.D | Emergency Medicine | Dallas, TX | $155.56 | 2 |
| , DPM | Podiatrist | Montgomery, AL | $155.51 | 4 |
| , MD | Infectious Disease | Altamonte Springs, FL | $155.41 | 7 |
| , M.D | Infectious Disease | Santa Monica, CA | $154.99 | 7 |
| , DPM | Foot & Ankle Surgery | Ocean Isle Beach, NC | $154.57 | 3 |
| , M.D | Infectious Disease | Houston, TX | $154.46 | 6 |
| , MD, MHA | Emergency Medicine | Port Washington, NY | $154.13 | 6 |
| , MD | Internal Medicine | Macon, GA | $154.05 | 10 |
| Chelsey Lesniak | Registered Nurse | Crystal Lake, IL | $153.70 | 5 |
| , MD | Acute Care | Dallas, TX | $153.30 | 3 |
| , M.D | Internal Medicine | Lake Monroe, FL | $152.69 | 7 |
| , DPM | Foot & Ankle Surgery | Sandusky, OH | $151.83 | 7 |
| , D.O | Internal Medicine | Westmont, IL | $151.29 | 2 |
| , DPM | Foot & Ankle Surgery | Itasca, IL | $151.07 | 17 |
| , M.D | Specialist | Houston, TX | $150.97 | 7 |
| , DPM | Podiatrist | Houston, TX | $150.26 | 2 |
| Jay Coates | Surgery | Atlanta, GA | $150.07 | 2 |
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $1.1M
- Total Doctors 3,950
- Transactions 10,635
About Kimyrsa
Kimyrsa is a drug associated with $1.1M in payments to 3,950 healthcare providers, recorded across 10,635 transactions in the CMS Open Payments database. The primary manufacturer is Melinta Therapeutics, LLC.
Payment data is available from 2021 to 2024. In 2024, $171,197 was paid across 1,307 transactions to 658 doctors.
The most common payment nature for Kimyrsa is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($409,910, 38.0% of total).
Kimyrsa is associated with 2 research studies, including "Anchoring Intermittent long acting antimicrobials to medication for opiod use disorder treatment to facilitate structure transitions of care for people who use drugs admitted to the hospital with invasive infections (AIM-STOP)" ($39,139).